Gianfranco Pasut is Full Professor of Pharmaceutical Technology at the Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Italy. He received his PhD in Pharmaceutical Sciences from the University of Padova in 2003. His research focuses on the design and development of innovative technologies for drug and protein delivery, with particular expertise in bioconjugation, polymer–protein conjugates, and targeted drug delivery systems.
Over more than two decades of research, Prof. Pasut has contributed to the development of novel strategies for the conjugation of polymers to proteins, with a particular focus on site-selective and enzymatic conjugation approaches. His work has led to the development of innovative conjugation technologies and to collaborations with pharmaceutical and biotechnology companies.
His current research interests include polymer–protein conjugates, antibody–drug conjugates (ADCs), targeted liposomes, and other advanced drug delivery systems. A particular focus of his research is the use of enzymes, including transglutaminase, for the site-selective modification and conjugation of proteins and the development of novel bioconjugates.
Prof. Pasut has authored more than 100 scientific publications and 17 book chapters and is an inventor on 14 patents. He is the scientific editor of Polymer–Protein Conjugates: From PEGylation and Beyond, a book dedicated to the development and applications of polymer–protein conjugation technologies.
He has served on scientific advisory boards and as a scientific consultant for several pharmaceutical companies. He is also Specialty Chief Editor of the Nano-Based Drug Delivery section of Frontiers in Medical Technology.
His research aims to develop innovative and clinically relevant strategies for the delivery of therapeutic proteins and drugs, with the goal of improving their efficacy, selectivity, and safety.
